Clinical Trials Browser

Phase 2/3 × Terminated × Antilymphocyte Serum × Clear all

NCT00176839 2017-12-05

Stem Cell Transplantation for Hematological Malignancies

Phase 2/3 Terminated

11 enrolled 12 charts

LymphoidOther hematologic neoplasm

Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma